1928DSA CE Marked

Computer screen showing the 1928DSA product in the 1928D platform.

1928DSA, our clinical decision support software for Staphylococcus aureus infections now has a CE mark (IVD, in vitro diagnostic device). We are happy that another step is taken to enable powerful diagnostics of MRSA infections by using whole genome sequencing. We are extremely proud over the hard work the whole 1928D development team has put in to reach this milestone and look forward to releasing new diagnostic products on the market.